11.6
Akari Therapeutics Plc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
13.8
FY23:
4.34
FY24:
2.95
FY25:
5.46
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0.02
FY23:
0.01
FY24:
47.6
FY25:
42.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
13.8
FY23:
4.36
FY24:
50.6
FY25:
47.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.09
FY22:
12.0
FY23:
4.58
FY24:
19.9
FY25:
12.4
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
8.42
FY25:
7.21
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.55
FY22:
1.79
FY23:
−0.23
FY24:
22.2
FY25:
28.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
13.8
FY23:
4.36
FY24:
50.6
FY25:
47.9
All amounts in millions USD